glycyl-proline-1-naphthylamide has been researched along with metformin in 1 studies
*Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) [MeSH]
*Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) [MeSH]
| Studies (glycyl-proline-1-naphthylamide) | Trials (glycyl-proline-1-naphthylamide) | Recent Studies (post-2010) (glycyl-proline-1-naphthylamide) | Studies (metformin) | Trials (metformin) | Recent Studies (post-2010) (metformin) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 17,793 | 3,176 | 12,526 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demuth, HU; Hinke, SA; Hoffmann, T; Kühn-Wache, K; McIntosh, CH; Pederson, RA | 1 |
1 other study(ies) available for glycyl-proline-1-naphthylamide and metformin
| Article | Year |
|---|---|
Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.
Topics: Animals; Dipeptides; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Humans; Hydrolysis; Hypoglycemic Agents; Kinetics; Metformin; Peptide Fragments; Protein Precursors; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Swine | 2002 |